Brigitte Draeger

Title: Brigitte Draeger: Innovator in Biochemical Processes

Introduction

Brigitte Draeger is a prominent inventor based in Tutzing, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of methods for analyzing blood components. With a total of 6 patents to her name, Draeger's work has had a substantial impact on medical diagnostics.

Latest Patents

One of her latest patents is a process for determining the binding capacity of thyroxin-binding globulin (TBG). This invention utilizes a heterogeneous enzyme immunoassay, where serum samples are incubated with enzyme-labelled T4 or T3 and an immobilized antibody against TBG or T4. The phases are then separated, allowing for the measurement of the labelling enzyme in one of the phases. Another notable patent is a method for the direct determination of the lipid content of blood. This method involves mixing blood plasma or serum with a solid, water-insoluble anion exchanger to retain pre-beta-lipoprotein (VLDL) and alpha-lipoprotein (HDL), thereby allowing for the determination of the remaining beta-lipoprotein (LDL) in solution.

Career Highlights

Brigitte Draeger is currently associated with Boehringer Mannheim GmbH, where she continues to innovate in her field. Her work has been instrumental in advancing diagnostic techniques that are crucial for understanding various health conditions.

Collaborations

Throughout her career, Draeger has collaborated with notable colleagues such as Joachim Ziegenhorn and Wolfgang Gruber. These partnerships have further enriched her research and development efforts.

Conclusion

Brigitte Draeger stands out as a leading inventor in the biochemical sector, with her patents contributing significantly to medical diagnostics. Her innovative approaches continue to influence the field and improve health outcomes.